Phase 2 Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 75 years old
- People who have been diagnosed with a confirmed cancer of the lung, liver, pancreas, or retroperitoneal area (the space at the back of the abdomen)
- People with metastatic cancer where the cancer has spread to only a limited number of sites (called oligometastasis)
- People whose tumour is either at least 2cm in its shortest measurement, or is located less than 5mm away from a nearby organ
- People who are largely able to carry out daily activities with little or no restriction (this is measured by a scoring system called ECOG, with a score of 0 or 1)
- People whose blood test results, liver and kidney function, and blood clotting levels fall within acceptable ranges as defined by the trial (confirm specific values with trial site)
Who may not be able to join:
- People who have previously had radiotherapy treatment on the same area being studied
- People who have had another cancer diagnosis within the past 5 years
- People whose daily activity is significantly limited due to their condition (an ECOG score of 2 or higher)
- People with significantly abnormal blood test results, or liver, kidney, or blood clotting function
- People with active inflammatory bowel disease, if the cancer involved is in the pancreas or retroperitoneal area
- People who have experienced gastrointestinal bleeding or a bowel perforation within the last 6 months, if the cancer involved is in the pancreas or retroperitoneal area
- People who currently have an infection that requires antibiotic treatment
- People with significant heart or breathing problems
- People who are pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Huojun Zhang, M.D., Changhai Hospital
Phone: 86-021-31162222
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
One-year local control will be determined.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.